Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/5195
Title: Comparison of initial efficacy and long-term follow-up of heparin-coated Jostent with conventional NIR stent
Authors: Semiz, Ender.
Ermiş, C.
Yalçinkaya, S.
Sancaktar, O.
Deger, N.
Keywords: Coating
Coronary disease
Coronary stents
Heparin
Restenosis
heparin
biomaterial
acute heart infarction
adult
aged
article
cardiovascular surgery
comparative study
controlled study
coronary artery bypass graft
coronary artery disease
coronary stent
emergency treatment
female
human
long term care
major clinical study
male
material coating
mortality
outcomes research
priority journal
restenosis
thrombosis
coronary artery thrombosis
follow up
heart muscle revascularization
middle aged
retrospective study
stent
Aged
Coated Materials, Biocompatible
Coronary Disease
Coronary Restenosis
Coronary Thrombosis
Female
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Revascularization
Retrospective Studies
Stents
Abstract: The implantation of heparin-coated stents was reported to be well tolerated, but there are conflicting results about acute in-hospital complications, (sub)acute thrombosis rates, and long-term follow-up compared to uncoated stents. We compared the angiographic and clinical results after coronary placement of two stent models: the heparin-coated premounted Jostent and the uncoated premounted NIR stent. Of 710 patients revascularized, a total of 426 patients received Jostent (n = 230) or NIR stent (n = 196) implantation. The primary end points were acute or subacute thrombosis, urgent CABG, AMI or death, while the secondary end points were the comparison of the restenosis rates of the stents at the 6th month and of the functional angina classification of the stent groups at the 1st, 6th and 12th months. There were no significant differences between the Jostent and NIR stent groups regarding angiographic and procedural success. Acute thrombosis rates in the Jostent and NIR stent groups were similar while no subacute thrombosis was observed in either group. The major adverse cardiac event rates of the groups also did not differ. Angiographic restenosis occurred in 17% of the Jostent group and 16% of the NIR stent group (NS). The combined clinical and angiographic restenosis rate was also similar between the Jo and NIR groups (19% and 18%, respectively). Comparison of functional angina classes at the 1st, 6th and 12th months revealed no significant difference between the study groups. In conclusion, when compared with implantation of an uncoated premounted NIR stent, implantation of a heparin-coated premounted Jostent does not provide any more benefit with respect to initial efficacy, sub(acute) thrombosis and 6-month restenosis rates and 12-month clinical outcomes. Copyright © 2004 by the Japanese Heart Journal.
URI: https://hdl.handle.net/11499/5195
https://doi.org/10.1536/jhj.44.889
ISSN: 0021-4868
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Files in This Item:
File SizeFormat 
44_889.pdf79.93 kBAdobe PDFView/Open
Show full item record



CORE Recommender

SCOPUSTM   
Citations

8
checked on Sep 30, 2024

WEB OF SCIENCETM
Citations

6
checked on Oct 8, 2024

Page view(s)

26
checked on Aug 24, 2024

Download(s)

16
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.